Topic · page 9 of 47

Lupus & antiphospholipid syndrome

Systemic and cutaneous lupus erythematosus, lupus nephritis, neuropsychiatric lupus, disease activity, remission and low disease activity, damage, antimalarials and targeted treatment; antiphospholipid antibodies and antiphospholipid syndrome, thrombotic and obstetric

Briefs 321–360 of 1,848 placed here, newest publication first

Briefs in Lupus & antiphospholipid syndrome

Newest publication first

Arthritis Res Ther21 Mar 2026
Beyond glomeruli: interstitial fibrosis and tubular atrophy predict poor renal outcomes in lupus nephritis
Cohort study
Arthritis Res Ther21 Mar 2026
Serum epitope-specific anti-recoverin autoantibodies as biomarkers for lupus retinopathy
Diagnostic or prognostic study
Lupus20 Mar 2026
Beyond glomeruli in lupus nephritis: Impact of tubulointerstitial inflammation and interstitial fibrosis/tubular atrophy on renal function decline – A systematic review and meta-analysis
Meta-analysis
Ann Rheum Dis20 Mar 2026
An immunometabolic signature of major depressive disorder in systemic lupus erythematosus
Cross-sectional study
Lupus19 Mar 2026
Gut and oral microbiota characterized in systemic lupus erythematosus patients from India: A pilot study
Case-control study
RMD Open19 Mar 2026
Anifrolumab in systemic lupus erythematosus: real-world evidence from a Spanish multicentre cohort of 206 patients and literature review
Cohort study
Arthritis Rheumatol19 Mar 2026
Dysregulation of U12 ‐Type Splicing in Lupus Neutrophils
Mechanistic study
Lupus Sci Med18 Mar 2026
Measurement of haemolytic anaemia in a novel treatment response measure for SLE clinical trials
Guideline or statement
Lupus Sci Med18 Mar 2026
Twelve-month follow-up after telitacicept withdrawal in patients with SLE: a single-centre study
Cohort study
Arthritis Res Ther18 Mar 2026
Treatment patterns, treat-to-target goals and clinical outcomes of patients with active lupus nephritis: real-world evidence from a multicentre cohort study
Cohort study
Ann Rheum Dis18 Mar 2026
Neutrophil transcriptomics in SLE reveals intrinsic disease signatures, shared ex vivo adaptation, and transcriptional reset after CAR T-cell therapy
Mechanistic study
Arthritis Res Ther16 Mar 2026
Increased soluble CD200 in serum of SLE patients does not reflect disease activity or affect CD200R1 function in T cells
Cross-sectional study
Arthritis Rheumatol16 Mar 2026
Anifrolumab Treatment Leads to Rapid Reduction in Urinary Biomarkers of Intrarenal Inflammation in Lupus Nephritis: Results From the Phase 2 Randomized Trial
Secondary analysis
Rheumatology (Oxford)16 Mar 2026
The impact of anti-SSA/Ro antibodies on pregnancy outcomes in patients with systemic lupus erythematosus
Cohort study
Lupus13 Mar 2026
Shrinking lung syndrome in systemic lupus erythematosus: Insights from a case series and a systematic review of the past decade
Meta-analysis
RMD Open13 Mar 2026
Hyposplenism in systemic lupus erythematosus: biological and radiological characteristics and its association with increased risk of infection
Case-control study
Lupus Sci Med13 Mar 2026
Left Ventricular Mass Index as an independent predictor of major adverse cardiovascular and cerebrovascular events in patients with SLE
Cohort study
Arthritis Care Res (Hoboken)13 Mar 2026
Systemic Lupus Erythematosus Mortality Among Decedents Aged ≥15 Years—United States, 2018–2023
Cross-sectional study
Lupus Sci Med12 Mar 2026
Serum IL-2 levels are associated with disease activity and related to dyslipidaemia and the immunological profile in systemic lupus erythematosus
Cross-sectional study
Clin Exp Rheumatol12 Mar 2026
Common femoral vein wall thickness in antiphospholipid syndrome: a potential imaging biomarker
Cross-sectional study
Lupus Sci Med11 Mar 2026
Biomarker-stratified efficacy and safety of biologics in systemic lupus erythematosus: a systematic review and meta-analysis
Meta-analysis
Lupus10 Mar 2026
Psychosis in patients with systematic lupus erythematosus: A systematic literature review and meta-analysis
Meta-analysis
Lupus Sci Med6 Mar 2026
Clinical utility and performance of anti-C1q antibodies for SLE: comparative analysis of three different assays
Cross-sectional study
N Engl J Med6 Mar 2026
Efficacy and Safety of Obinutuzumab in Active Systemic Lupus Erythematosus
Randomized controlled trial
Lupus6 Mar 2026
Neutralizing autoantibodies against interferon alpha in systemic lupus erythematosus: Prevalence, age of onset, and clinical associations
Cross-sectional study
Arthritis Care Res (Hoboken)6 Mar 2026
Rheumatologic Manifestations of Patients With Type B Insulin Resistance
Cohort study
Ann Rheum Dis5 Mar 2026
Progression from at-risk state to clinical and severe systemic lupus erythematosus involves molecular dysregulations potentially reversible by biologics: implications for early diagnosis and treatment
Cohort study
RMD Open4 Mar 2026
Distinct pattern of comorbidities hinders treatment target attainment in SLE through persistent disease activity and delayed glucocorticoid tapering: longitudinal data from a multicentre cohort study
Cohort study
Lupus Sci Med3 Mar 2026
High incidence of herpes zoster among SLE patients in Indonesia: a retrospective cohort study
Cohort study
Lupus3 Mar 2026
Reasons for ICU admissions and mortality in systemic lupus erythematosus in a South Indian tertiary centre - An observational study
Cohort study
Lupus2 Mar 2026
The intervention to improve quality of life for African American lupus patients project: Incorporating the element of choice to improve disease self-management and quality of life: A randomized controlled study
Randomized controlled trial
Lupus2 Mar 2026
Long-term steroid-sparing effect of belimumab in systemic lupus erythematosus: Post hoc pooled analysis of OBSErve multi-country cohort data
Meta-analysis
J Rheumatol1 Mar 2026
Differences in Self-Reported Medication Nonadherence and Its Drivers in Young Adults Versus Older Adults With Systemic Lupus Erythematosus
Cross-sectional study
Lupus27 Feb 2026
Clinical, serological, and targeted genetic analysis of systemic lupus erythematosus in Kazakhstan
Cross-sectional study
Lupus25 Feb 2026
Protective effect of antimalarials on the most frequently affected damage domains in SLE: Data from a multiethnic Latin American cohort
Cohort study
RMD Open25 Feb 2026
Development of a novel meta-polygenic risk score for risk assessment and clinical manifestation prediction in systemic lupus erythematosus
Case-control study
Lupus25 Feb 2026
Expression levels of miR-146a-5p, miR-155-5p and the pro-inflammatory cytokine IL-8 in pregnant women with anti-phospholipid syndrome
Case-control study
Lupus25 Feb 2026
Association of systemic lupus erythematosus with clinical and psychosocial outcomes, health care resource utilization and expenditures: A nationally representative US-based analysis
Cross-sectional study
Arthritis Rheumatol25 Feb 2026
Low‐Grade Proteinuria Does Not Predict Favorable Outcomes in Lupus Nephritis: A Longitudinal Cohort Study
Cohort study
Lupus Sci Med23 Feb 2026
Sex-based clinical and immunological differences across lupus erythematosus subtypes: a cross-sectional multicentre study from China
Cross-sectional study

All 1,848 Briefs in ExploreShowing Briefs 321–360 of 1,848, newest first